Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome

• Ilana D. Breen, BS,
• Caitlin M. Brumfiel, MS,
• Meera H. Patel, BS,
• Allison C. Rosenthal, DO,
• William G. Rule, MD,
• David J. DiCaudo, MD,
• Fiona E. Craig, MD,
• Mark R. Pittelkow, MD,
• Aaron R. Mangold, MD

Affiliations

Ilana D. Breen, BS

Mayo Clinic Alix School of Medicine, Scottsdale, Arizona; Correspondence to: Ilana D. Breen, BS, Mayo Clinic Alix School of Medicine, 13400 E Shea Blvd, Scottsdale, AZ 85259.

Caitlin M. Brumfiel, MS

Mayo Clinic Arizona, Dermatology, Scottsdale, Arizona

Meera H. Patel, BS

Mayo Clinic Arizona, Dermatology, Scottsdale, Arizona

Allison C. Rosenthal, DO

Mayo Clinic Arizona, Hematology Oncology, Phoenix, Arizona

William G. Rule, MD

Mayo Clinic Arizona, Radiation Oncology, Phoenix, Arizona

David J. DiCaudo, MD

Mayo Clinic Arizona, Dermatology, Scottsdale, Arizona; Mayo Clinic Arizona, Laboratory Medicine and Pathology, Phoenix, Arizona

Fiona E. Craig, MD

Mayo Clinic Arizona, Laboratory Medicine and Pathology, Phoenix, Arizona

Mark R. Pittelkow, MD

Mayo Clinic Arizona, Dermatology, Scottsdale, Arizona

Aaron R. Mangold, MD

Mayo Clinic Arizona, Dermatology, Scottsdale, Arizona